Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter April 13, 2017

Can we still trust hemoglobin A1c in all situations?

Elisa Danese, Martina Montagnana, Gian Luca Salvagno and Giuseppe Lippi ORCID logo

Corresponding author: Prof. Martina Montagnana, Section of Clinical Biochemistry, University of Verona, Verona, Italy

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. American Diabetes Association. Statistics About Diabetes. Available at: http://www.diabetes.org/diabetes-basics/statistics/. Accessed 8 Feb 2017.Search in Google Scholar

2. Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA: US Department of Health and Human Services; 2014.Search in Google Scholar

3. American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care 2016;39(Suppl 1):S13–22.10.2337/dc16-S005Search in Google Scholar PubMed

4. Lippi G, Targher G. Glycated hemoglobin (HbA1c): old dogmas, a new perspective? Clin Chem Lab Med 2010;48:609–14.10.1515/CCLM.2010.144Search in Google Scholar PubMed

5. Lippi G, Targher G. A laboratory standpoint on the role of hemoglobin A1c for the diagnosis of diabetes in childhood: more doubts than certainties? Pediatr Diabetes 2011;12:183–6.10.1111/j.1399-5448.2010.00684.xSearch in Google Scholar PubMed

6. Salinas M, López-Garrigós M, Flores E, Leiva-Salinas M, Lugo J, Pomares FJ, et al. Automatic laboratory-based strategy to improve the diagnosis of type 2 diabetes in primary care. Biochem Med (Zagreb) 2016;26:121–8.10.11613/BM.2016.013Search in Google Scholar PubMed PubMed Central

7. Lacy ME, Wellenius GA, Sumner AE, Correa A, Carnethon MR, Liem RI, et al. Association of sickle cell trait with hemoglobin A1c in African Americans. J Am Med Assoc 2017;317:507–15.10.1001/jama.2016.21035Search in Google Scholar PubMed PubMed Central

8. Rohlfing C, Hanson S, Weykamp C, Siebelder C, Higgins T, Molinaro R, et al. Effects of hemoglobin C, D, E and S traits on measurements of hemoglobin A1c by twelve methods. Clin Chim Acta 2016;455:80–3.10.1016/j.cca.2016.01.031Search in Google Scholar PubMed PubMed Central

9. You-Qiong L, Hui-Ping H, Zhi-Zhong C, Lin Z, Liang L, Gui-Fang Q, et al. Comparison of capillary electrophoresis and high performance liquid chromatography for detection and quantification of hemoglobin New York. Clin Chem Lab Med 2016;54:91–5.10.1515/cclm-2015-0238Search in Google Scholar PubMed

10. Ji L, Yu J, Zhou Y, Xia Y, Xu A, Li W, et al. Erroneous HbA1c measurements in the presence of β-thalassemia and common Chinese hemoglobin variants. Clin Chem Lab Med 2015;53:1451–8.10.1515/cclm-2014-0598Search in Google Scholar PubMed

11. Lippi G, Plebani M. Capillary electrophoresis for the screening and diagnosis of inherited hemoglobin disorders. Ready for prime time? Clin Chem Lab Med 2016;54:5–6.10.1515/cclm-2015-0545Search in Google Scholar PubMed

12. Yun YM, Ji M, Ko DH, Chun S, Kwon GC, Lee K, et al. Hb variants in Korea: effect on HbA1c using five routine methods. Clin Chem Lab Med 2017. doi: 10.1515/cclm-2016-0865. [Epub ahead of print].10.1515/cclm-2016-0865Search in Google Scholar PubMed

13. Kabytaev K, Connolly S, Rohlfing CL, Sacks DB, Stoyanov AV, Little RR. Higher degree of glycation of hemoglobin S compared to hemoglobin A measured by mass spectrometry: potential impact on HbA1c testing. Clin Chim Acta 2016;458:40–3.10.1016/j.cca.2016.04.027Search in Google Scholar PubMed PubMed Central

14. Lee BS, Jayathilaka GD, Huang JS, Vida LN, Honig GR, Gupta S. Analyses of in vitro nonenzymatic glycation of normal and variant hemoglobins by MALDI-TOF mass spectrometry. J Biomol Tech 2011;22:90–4.Search in Google Scholar PubMed

15. Lipska KJ, Krumholz HM. Is hemoglobin A1c the right outcome for studies of diabetes? J Am Med Assoc 2017;317:1017–8.10.1001/jama.2017.0029Search in Google Scholar PubMed PubMed Central

16. Rodríguez-Gutiérrez R, Montori VM. Glycemic control for patients with type 2 diabetes mellitus: our evolving faith in the face of evidence. Circ Cardiovasc Qual Outcomes 2016;9:504–12.10.1161/CIRCOUTCOMES.116.002901Search in Google Scholar PubMed PubMed Central

17. Sacks DB, John WG. Interpretation of hemoglobin A1c values. J Am Med Assoc 2014;311:2271–2.10.1001/jama.2014.6342Search in Google Scholar PubMed

Received: 2017-2-8
Accepted: 2017-3-15
Published Online: 2017-4-13
Published in Print: 2017-10-26

©2017 Walter de Gruyter GmbH, Berlin/Boston